NASDAQ: EXAS 58.87
Change: +0.37 +0.63% Minimum 20 min delay
3:59 PM ET on Nov 17, 2017
Volume: 986,192

Exact Sciences to host second-quarter 2017 results, annual meeting webcasts and calls

07/10/2017

MADISON, Wis., July 10, 2017 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls to discuss its second-quarter 2017 financial results and of its annual stockholders meeting.

Exact Sciences Corporation Logo (PRNewsfoto/EXACT SCIENCES CORP)

Second-Quarter 2017 Webcast & Conference Call Details

Date:          

Tuesday, July 25, 2017

Time:           

5 p.m. ET, 4 p.m. CT

Webcast:      

The live webcast can be accessed at www.exactsciences.com

Telephone:        

Domestic callers, dial 877-201-0168
International callers, dial +1 647-788-4901


Access code for both domestic and international callers: 51121804

 

Annual Meeting of Stockholders Webcast & Conference Call Details

Date:             

Thursday, July 27, 2017

Time:              

11 a.m. ET, 10 a.m. CT

Webcast:        

The live webcast can be accessed at www.exactsciences.com

Telephone:      

Domestic callers, dial 877-201-0168
International callers, dial +1 647-788-4901


Access code for both domestic and international callers: 51903836

 

An archive of the webcast will be available at www.exactsciences.com.  A replay of the second-quarter and annual meeting conference calls will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the second-quarter call is 51121804. The annual meeting replay can be accessed with the code 51903836. The webcasts, conference calls and replays are open to all interested parties.

About Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences or find Exact Sciences on Facebook.

Certain statements made in this news release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, that are intended to be covered by the "safe harbor" created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "could," "seek," "intend," "plan," "estimate," "anticipate," or other comparable terms. Forward-looking statements in this news release may address the following subjects among others: the terms and size of the offering and the use of proceeds from the offering. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of the Company's most recently filed Annual Report on Form 10-K and the Company's subsequently filed Quarterly Reports on Form 10-Q. The Company urges you to consider those risks and uncertainties in evaluating the Company's forward-looking statements. The Company cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Contact:
Megan Reiss
Exact Sciences Corp.
Investor Relations Analyst
meganreiss@exactsciences.com
608-535-8815

View original content with multimedia:http://www.prnewswire.com/news-releases/exact-sciences-to-host-second-quarter-2017-results-annual-meeting-webcasts-and-calls-300485015.html

SOURCE EXACT SCIENCES CORP